Infographic: Inducing Active Immunity Against Opioid Overdose | TS Digest | The Scientist – The Scientist

Current Issue
Current Issue
Tori Rodriguez is an Atlanta-based freelance writer, author, and psychotherapist who has treated clients with substance use disorders.
View full profile.
Learn about our editorial policies.
ABOVE: © catherine delphia
Due to their small molecular size, opioids can cross the blood-brain barrier (BBB) to cause both the euphoria that makes such drugs so addictive and the adverse effects including the respiratory depression that can cause fatal overdose via inhibition of neural networks that regulate breathing (left panel). To fight opioid use disorder (OUD) and reduce overdose deaths, scientists have designed a handful of experimental vaccines, which are just beginning to enter human testing. These experimental vaccines involve a carrier protein studded with analogs of the opioid, called haptens, combined with adjuvants that strengthen the overall immune response (middle panel). Antibodies generated against haptens will bind to the opioid, blocking it from crossing the BBB due to the antibodies’ large size (right panel). The hope is that if people recovering from OUD receive a vaccine targeting their drug of abuse and then relapse, they will not experience respiratory depression that can lead to overdose or the euphoric effects that reinforce the drug-seeking behavior.

While it may seem counterintuitive, some drugs used to treat opioid use disorder (OUD) activate opioid receptors in the brain. Methadone is a full opioid agonist, binding to and activating opioid receptors while blocking the binding of other opioids. It is longer-acting than opioids such as heroin and oxycodone, however, so it can provide a mild, controlled “hit” to reduce withdrawal symptoms such as drug craving, gastrointestinal distress, and accelerated heart rate. Another OUD treatment approved in the US is buprenorphine, a partial opioid agonist that binds to but only partially activates the receptor. A third option, naltrexone, is an opioid antagonist, meaning that it blocks opioids from binding the receptors without any activation. In addition, the overdose antidote naloxone can be used to treat overdose itself. It is an opioid antagonist that knocks opioid molecules off the opioid receptors and takes their place.

Drugs for OUD
Drug for reversing overdose
Binds and fully activates
Binds and partially activates
Binds but doesn’t activate
Knocks opioid off receptors
Read the full story.
This article was featured in June 2022, Issue 2 of the digest
This Issue
Can the immune system help prevent overdose and treat addiction?
Already a Member?
© 1986–2022 The Scientist. All rights reserved.